Cancer research

Cancer is a multifaceted disease that arises from numerous modifications to the cellular genome including gene mutations, copy number variations, and structural changes such as chromosomal translocations and deletions. These genomic alterations, in parallel with dysregulations within the epigenetic landscape, are hallmarks of cancer and account for the complexity of the disease.

The fight against cancer remains an uphill battle. The efficacies of traditional treatments for cancer such as radiotherapy and chemotherapy are often limited by the occurrence of severe toxicities, resulting in serious and life-threatening side effects. However, ongoing advances in cancer immunotherapy offer great hope in the fight against cancer as they utilize components of a patient's own immune system to selectively target and kill cancer cells, thus mitigating many of the side effects associated with traditional treatment options. 

We offer a broad range of innovative technologies to accelerate your cancer research and drug discovery workflows. These tools are applicable to research areas such as cancer biomarker discovery and quantification, single cancer cell analysis, cancer epigenomic analysis, HLA typing, T-cell therapy and profiling, antibody therapeutics, and CRISPR/Cas9 gene editing.